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CASE 1
A 28-year-old woman was referred to an epilepsy and
neuropsychiatry service following a disastrous attempt
at treating her infertility by a local gynaecological unit.
At the age of 14 she had developed complex partial
seizures. A single electroencephalograph (EEG) had
shown epileptic activity focal to the right temporal
lobe and she was placed on sodium valproate by a
paediatrician. She continued to have several complex
partial seizures a year despite this medication and
gained a great deal of weight. Her periods became
irregular and finally stopped at the age of 20. She was
discharged from paediatric care at the age of 18, but
was not referred for further secondary care, however,
she was managed by her General Practitioner (GP)
who continued her prescriptions.
At the age of 22 she married and attempted to
conceive. She did not become pregnant and at the
age 26 was seen by a gynaecologist for her infertility.
Her amenorrhoea was investigated, she was shown
to have the polycystic ovary syndrome and, without
further consideration, treated with clomiphene to
induce ovulation—the epilepsy, and the possible
consequences of the medication she was taking,
were ignored even though her seizure frequency
dramatically increased during the three courses of
clomiphene she had: during the courses of clomiphene
she received artificial insemination from her husband.
To her delight she conceived: later screening,
however, showed her to be carrying a child with a
severe spina bifida (she had not been offered folic
acid) and she and her husband reluctantly agreed
to a termination of pregnancy at 20 weeks. She
became very depressed and was referred to the
neuropsychiatry clinic, more for her mental state than
her epilepsy: she was having frequent seizures.
Her depression was talked through, but not treated
with anti-depressants and she recovered. Her epilepsy
was investigated: there was a clear right temporal
focus on electroencephalography and right hippocam-
pal sclerosis shown on magnetic resonance imaging
(MRI). A right temporal lobectomy was suggested:
whilst waiting for this operation, lamotrigine was
substituted for valproate and she rapidly became
seizure free. She quickly lost weight: both her sexual
desire and her periods returned and a few months later
she found herself unexpectedly pregnant. She had a
subsequent normal delivery of a normal baby, and has
had a further successful pregnancy since. She remains
seizure free and has not had the operation.
When she became seizure free she had a transient se-
vere affective psychosis with some paranoid ideation,
which required brief chemotherapy. She had a brief
recurrence of this illness for a short while after both
confinements, but both episodes lifted spontaneously.
Comment
This case illustrates the need to manage people with
epilepsy holistically and for other specialists not to
neglect the patient’s epilepsy (and the possible con-
sequence of its treatment) whilst pursuing some other
therapeutic goal. It also illustrates the need for better
hand over care at the end of paediatric supervision.
We encourage our gynaecological colleagues, as-
sessing women with epilepsy with infertility prob-
lems, to refer them across for re-assessment of their
epilepsy and its treatment before starting therapy for
the infertility. Our experience is that clomiphene can
often increase seizure frequency (or re-activate quies-
cent epilepsy) and we warn our obstetric colleagues of
the teratogenic potential of valproate (which they often
seem unaware of).
Only further research will tell us if this woman’s
sudden reversion from the polycystic ovary syndrome
into normal menstruation and fertility was due to
the withdrawal of valproate, the effect of cloniphene,
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the control of her seizures, or the exhibition of
lamotrigine (or all four) but, as mentioned in the
review, we have some preliminary evidence that it
may be a lamotrigine effect and, following a few
other unexpectedly early pregnancies, routinely warn
women switching from valproate to lamotrigine in our
preconception clinic to stick to effective contraceptive
practice, until the switch is fully complete, and ensure
they are taking prophylactic folic acid1.
CASE 2
A girl of 11 had two witnessed tonic–clonic seizures
in her sleep: EEG examination showed a typical
pattern of generalized epilepsy. She was put on sodium
valproate, the dose was built up to one gram daily and
she had no more seizures.
She started to menstruate at the age of 9, but had
not established a regular menstrual cycle by the time
she took valproate. She had one or two further periods
thereafter but then had no more periods from the age of
13. She steadily gained weight during her adolescence,
developed a degree of male pattern hirsutism, a gruff
voice and clitoral enlargement.
At the age of 22 she was referred by her GP to a
physician to determine whether she could withdraw
from the valproate as she wished to have children. In
his letter to the GP the physician stated that he ‘had
read somewhere’ that valproate ‘could cause poly-
cystic ovaries’, added in phenytoin to her valproate
(presumably with the intention of later withdrawing
the valproate) and investigated her amenorrhoea.
Follicle stimulating and luteinizing hormone levels
were normal as was her prolactin level: but her testos-
terone level was very high, three times above the upper
limit quoted by the laboratory. Abdominal ultrasound
showed no ovarian abnormality but the examination
was technically difficult to interpret due to her obesity:
being a virgin she declined transvaginal ultrasound.
It was decided that she had the polycystic ovary
syndrome, so the valproate was withdrawn, but her
periods did not return. Nine months after withdrawal
of the valproate she had a tonic–clonic seizure in the
bathroom in the early morning and began to develop
multiple myoclonic jerks later in the morning.
She was referred for re-investigation of her epilepsy
and a diagnosis of juvenile myoclonic epilepsy was
made. She was also photosensitive. Phenytoin was
withdrawn and lamotrigine substituted, the dose being
slowly escalated until all traces of photosensitivity had
gone: she had no more seizures or myoclonic jerks.
Re-investigation of her amenorrhoea showed a high
testosterone level as before: MRI scanning of her
ovaries revealed ovaries slightly smaller than normal,
with multiple small atretic cysts (not a typical picture
of polycystic ovaries). A search was then made for
other causes of her high testosterone level and MRI of
the abdomen revealed an androgen secreting tumour
of the left adrenal gland.
Comment
This case illustrates the importance of arriving at
correct syndromic classification before deciding on
withdrawal of medication. The girl had been having
morning jerks for some time before her first two
tonic–clonic seizures but their diagnostic importance
was ignored. Juvenile myoclonic epilepsy will return
even after many years of full control of seizures if
medication is then withdrawn.
It should have been recognized that there are
other causes for a high testosterone level than the
polycystic ovary syndrome and that the clinical history
was one of progressive virilization: the girl should
have been assessed first by an endocrinologist. The
choice of phenytoin as a substitute for valproate was
an irrational one and the clinician who decided on
this was almost certainly unaware of the complex
interaction between the two drugs, which can lead
to serious if inadvertent phenytoin intoxication2. He
should also have known that withdrawal seizures can
occur many months after withdrawal of valproate.
In other words he was acting outside his knowledge
base and should have sought the advice of colleagues.
Following successful treatment the girl is losing her
virilization, is menstruating and is seizure free: but is
not yet pregnant.
CASE 3
A woman of 32 presented in the triage clinic
of an epilepsy service having had two witnessed
tonic–clonic seizures whilst at work the previous
week. There was a clear witness description of the
events and the nurse running the clinic was satisfied
that they were epileptic in nature and arranged
the necessary investigations. There was no previous
history of epilepsy. She correctly enquired if the
woman had had any warning that the seizures might
be coming but was told there had been no warning:
they had come out of the blue.
Her only other health problem was her irregular
menstruation, so irregular that she had not had a period
for the previous 18 months. She was known to have the
polycystic ovary syndrome and had been told that she
would need hormone treatment (clomiphene) when
she wished to become pregnant. She accepted this as
both her mother and her sister had the same problem.
Her mother had just developed type II diabetes.
231
A couple of weeks later the consultant and nurse
were reviewing the patient in the clinic: EEG
examination had shown a clear cut epileptic focus in
the left temporal area, but head MRI scanning was
normal. On further questioning about any sequalae
after the two seizures she blushed, looked at the (male)
doctor with some alarm, turned to the (female) nurse
and said ‘well, you know, I’ve not had one of my
female funnies since I had the fits’.
It transpired that since the age of 14, she had
been having regular occurrences of warm sexual
feelings starting in her vagina and spreading to her
abdomen. They were intense and accompanied by
‘pleasant thoughts’. They only lasted a few seconds:
those who knew her well might notice them, she
thought, because she flushed and became pre-occupied
(but did not lose awareness). She enjoyed them,
particularly if they occurred when she was bored,
and had never considered them to be abnormal: she
thought all women had them, but just did not talk
about them. They had been intermittent all her life,
without obvious pattern, but had been particularly
frequent in the month or two before her seizures and
had disappeared after them.
Investigations also showed the typical hormonal
parameters of the polycystic ovary syndrome, with
raised testosterone and luteinizing hormone levels.
Pelvic MRI scanning showed bilateral enlarged
ovaries with multiple enlarged cysts. She was not
having treatment for the syndrome.
Lamotrigine was introduced in monotherapy and the
dose slowly escalated (to a 150 mg total daily dose)
until ‘the female funnies’ which had returned (and
were obviously simple partial seizures) disappeared
again: she has been totally seizure free for over a
year. Two months after starting lamotrigine (at a dose
of 50 mg per day) she started to menstruate, and is
now menstruating regularly. A repeat of her hormone
assessment (at the right time of the cycle—day four
of menstruation) showed a normal testosterone and
luteinizing hormone level: repeat MRI scanning of her
ovaries a year after menstruation restarted now showed
normal sized ovaries and normal sized cysts. She is not
yet trying to get pregnant, but is using reliable non-
hormonal contraception.
Comment
Sexual feelings are a not uncommon aura in women
with epilepsy3, but are often not disclosed to male
doctors, or not recognized for what they are or not
enquired about. They may, of course, be equally
common in men, but since men’s spontaneous sexual
feelings bounce about like yo-yos all day long anyway,
they may just not be recognized as abnormal!
The apparent cessation of this woman’s familial
polycystic ovary syndrome following the exhibition
of lamotrigine is interesting: but might equally well
be due to the cessation of left temporal lobe epileptic
activity which has also been shown to contribute to
the exacerbation of the polycystic ovary syndrome in
women with epilepsy4.
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Self-assessment questions
Question 1.
Which of the following statements are true?
(a) At the end of reproductive life, when the oocyte mass is exhausted, the quiescent ovary becomes an
‘indifferent gonad’.
(b) Luteinizing hormone release at midcycle increases testosterone production in the ovary.
(c) High follicle stimulating hormone levels decrease oestrogen levels.
(d) Increased insulin levels increase androgen production in the ovary.
(e) Atretic ovarian follicles become ovulatory follicles through the action of tumour necrosis factor (TNF).
Question 2.
Which of the following statements are true?
(a) Resection of the ovaries leads to resolution of the symptoms of the polycystic ovary syndrome.
(b) Women who have more than 10 cysts in their ovaries on ultrasound examination have the polycystic ovary
syndrome.
(c) Girls with type I diabetes are likely to have the polycystic ovary syndrome.
(d) Women with epilepsy have an altered LH pulse frequency.
(e) Women with left temporal lobe epilepsy are more likely to have polycystic ovaries.
Question 3.
Which of the following statements are true?
(a) Women with epilepsy are more likely to have anovulatory cycles.
(b) Anovulatory cycles lead to a reduction in seizure frequency in women due to increased progesterone levels.
(c) There is a probable association between the polycystic ovary syndrome and insulin resistance.
(d) Women taking sodium valproate have a greater prevalence of polycystic ovaries.
(e) The polycystic ovary syndrome can occur before puberty.
Question 4.
Infants born to women receiving antiepileptic drugs have:
(a) no additional risk of being born with an anomaly or a malformation.
(b) at least double the risk of being born with an anomaly or a malformation.
(c) at least triple the risk of being born with an anomaly or a malformation.
(d) at least quadruple the risk of being born with an anomaly or a malformation.
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Question 5.
Which of the following statements are true?
(a) By the time a woman with epilepsy presents in pregnancy it is too late to change AED therapy.
(b) All anti-epileptic drugs are equally teratogenic in pregnancy.
(c) Children born to mothers taking sodium valproate during pregnancy have a higher risk of needing help at
school.
(d) The risk of spina bifida associated with sodium valproate therapy can be reduced by decreasing the dose of
sodium valproate or changing to Epilim Chrono.
(e) All women with epilepsy should take high dose folic acid for a month before and 3 months after conception.
Question 6.
Which of the following statements are true?
(a) Treatment of choice for women with primary generalized epilepsy is sodium valproate.
(b) All women with epilepsy should have preconception counselling.
(c) All women with epilepsy need Vitamin K prophylaxis in the last month of pregnancy.
(d) Breast feeding is contra-indicated for women on anti-epileptic drugs.
(e) Anti-epileptic drug levels should be measured during pregnancy.
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Answers
1. (a) is false: the indifferent gonad is the undifferentiated gonadal tissue found in the very early embryo.
(b) is true.
(c) is false: it is the other way round.
(d) is true.
(e) is false: TNF causes apoptosis of the follicle.
2. (a) is true: but hardly an appropriate treatment. Resection of a wedge of ovarian tissue or of one ovary will
reduce androgen production from the ovary and may restore ovulation, at least for a while, and may
temporarily restore fertility.
(b) is false: they have polyfollicular ovaries (European definition).
(c) is false: it is type II diabetes.
(d) is true (probably).
(e) is true: in the sense there is published evidence for this, but probably an artefact of small numbers:
women with generalized epilepsy also have them.
3. (a) is true.
(b) is false: they lead to an increased number of seizures due to unopposed action of oestrogen.
(c) is true.
(d) is false.
(e) is false: polyfollicular ovaries can be detected before puberty. The polycystic ovary syndrome may
appear quite early on in puberty but not before it.
4. (a) is false.
(b) is true.
(c) is false.
(d) is false.
5. (a) Is true: by day 56 after conception the foetus is fully formed.
(b) Is false. Valproate is significantly more teratogenic than carbamazepine in the UK pregnancy database.
Some drugs (lamotrigine, gabapentin, tiagabine and levetiracetam) do not appear to be teratogenic in
animal studies. We are still awaiting human data.
(c) Is true.
(d) Is true. The teratogenicity of sodium valproate is dose dependent and relates to peak dose concentrations
which can be reduced by use of a Chrono preparation.
(e) Is true. The increased incidence of spina bifida associated with sodium valproate and carbamazepine
therapy. Folic acid has not been shown to definitely decrease this risk. There are suggestions that women
with epilepsy have a slightly increased risk of spina bifida than the general population.
6. (a) Is false. Sodium valproate is significantly more teratogenic than carbamazepine. Currently lamotrigine
is tending to be used in women of childbearing age.
(b) Is true.
(c) Is false. Only those on enzyme inducing drugs need Vitamin K prophylaxis.
(d) This is false—although all anti-epileptic drugs are excreted in breast milk in varying concentrations
according to the drug. It is rare for the baby to experience side effects. Occasionally this can
happen with phenobarbitone, benzodiazepines and lamotrigine and lamotrigine, especially in the very
premature.
(e) Is false. Total AED concentrations are misleading. If monitoring of blood levels is desired, free levels
need to be measured. However, it is better to treat the patient clinically, i.e. if seizures increase the dose
of anti-epileptic drug is increased.
